PANews reported on October 11th that Aethir's co-founder announced that its digital asset reserve (DAT), Predictive Oncology (NASDAQ: POAI), has officially launched on the Nasdaq under the ticker symbol $POAI. Over the next 45 days, the reserve will purchase $45 million worth of $ATH from the open market.
Earlier news reported that Predictive Oncology completed US$343.5 million in PIPE financing and plans to support the ATH token treasury strategy.
